Potential Adverse Effects The FDA flagged concerns about: Immunogenicity and antibody formation with repeated dosing Peptide-related impurities from compounding pharmacy manufacturing Unknown effects on cardiovascular, hepatic, and renal function with chronic use Theoretical acceleration of undetected tumor growth Current Research Gaps The literature reveals critical knowledge deficits preventing definitive cancer risk conclusions: Long-term human safety: No prospective study has followed BPC-157 users for months or years to document cancer incidence or tumor progression
The peptide demonstrates a strong safety profile, with research noting it has a long history of safe use in wound healing and skin care
Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage
The pain tends to go away quite quickly, however, if you are experiencing swelling, pain, and redness at the injection spot after a few days, contact a medical professional immediately
In the SURMOUNT trials, participants experienced significant reductions in fasting insulin, HbA1c (even in non-diabetic participants), triglycerides, and blood pressure
Case Rep